BB Biotech
Schaffhausen Canton of Schaffhausen (HQ)
Financials
Estimates*
| CHF | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 685m | 699m | (396m) | (351m) | (200m) |
| % growth | - | 2 % | (157 %) | (11 %) | (43 %) |
| Profit | 677m | 691m | (405m) | (358m) | (207m) |
| % profit margin | 99 % | 99 % | 102 % | 102 % | 104 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | $225k | Post IPO Equity |
| Total Funding | - | ||
Related Content
Recent News about BB Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by BB Biotech
Edit
ACQUISITION by AstraZeneca Dec 2020
ACQUISITION by Takeda Jan 2017
ACQUISITION by Valeant Pharmaceuticals International Feb 2012
